However, a randomized, double-blind, placebo-controlled trial using oral capsules of chamomile extract (standardized to 1.2% apigenin) in patients with mild-to-moderate anxiety (1) and an open-label trial for moderate-to-severe generalized anxiety disorder (2) showed possible modest antianxiety activity.